Drawing for ELI LILLY AND COMPANY

USPTO serial 71089413

ELI LILLY AND COMPANY

Reviewed by CopyMark Law Group

Reg. 0113361Status 800Renewal
Filing date
Status date
Registration date
Oct 17, 1916
Examiner
—
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with ELI LILLY AND COMPANY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John R. Rudolph

John R. Rudolph ELI LILLY AND COMPANYLilly Corporate CenterINDIANAPOLIS, IN 46285-0001United States

Goods and services

ClassDescriptionStatusFirst use
018[ FLUID EXTRACTS FOR MEDICINAL USES, PILLS, PINK GRANULES, ASEPTIC HYPODERMATIC TABLETS, VETERINARY HYPODERMATIC TABLETS, MEDICATED TABLETS, COMPRESSED MEDICINAL LOZENGES, ] ELIXIRS, [ SYRUPS FOR MEDICINAL PREPARATIONS, MEDICINAL WINES, MEDICINAL CORDIALS, SOLID EXTRACTS, POWDERED EXTRACTS, CONCENTRATIONS, ] FILLED CAPSULES, [ GLYCERITES, YERBAZIN, PIL. APHRODISIACA, SUPPOSITORIES, ALTERATIVE JUICES, LAXATIVES, ] MEDICINAL COMPOUNDS IN SOLID AND LIQUID FORM, [ ALL PHARMACEUTICALS, CHEMICALS, AND ANALOGOUS PRODUCTS USED FOR MEDICINAL PURPOSES OF THE CHARACTER DESCRIBED IN THE CATALOGUE ] FILED AND MADE A PART OF THE RECORD IN THIS CASEACTIVEJan 1, 1881

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 31, 2026CORVREVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD—
Dec 15, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Nov 1, 2025PR15POST REGISTRATION ACTION MAILED - SEC. 15—
Oct 17, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Oct 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 25, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 15, 2025E15RTEAS SECTION 15 RECEIVED—
Dec 22, 2016NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Dec 22, 2016RNL6REGISTERED AND RENEWED (SIXTH RENEWAL - 10 YRS)—
Dec 22, 201689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Dec 21, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 12, 2016E89RTEAS SECTION 8 & 9 RECEIVED—
Oct 17, 2015REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 12, 2009CFITCASE FILE IN TICRS—
Dec 14, 2006RNL5REGISTERED AND RENEWED (FIFTH RENEWAL - 10 YRS)—
Dec 14, 200689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Dec 14, 2006PLGLASSIGNED TO PARALEGAL—
Oct 13, 200689AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Oct 13, 2006E89RTEAS SECTION 8 & 9 RECEIVED—
Oct 31, 1996RNL4REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)—
Sep 5, 19969.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—
Sep 5, 19969.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8—
Oct 17, 1976REN3REGISTERED AND RENEWED (THIRD RENEWAL - 20 YRS)—

Frequently asked questions

Related guidance